This site is intended for healthcare professionals
News

FDA grants accelerated approval for Tazverik to treat follicular lymphoma. Epizyme Inc.

Read time: 1 mins
Last updated:23th Jun 2020
Published:22th Jun 2020
Condition: Follicular Lymphoma
Type: drug
Register free for full access to medthority.com